BlackRock Investment Management’s MediciNova MNOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$676K Buy
112,144
+779
+0.7% +$5.49K ﹤0.01% 2913
2016
Q3
$834K Sell
111,365
-196
-0.2% -$1.32K ﹤0.01% 2781
2016
Q2
$842K Buy
111,561
+107,276
+2,504% +$776K ﹤0.01% 2752
2016
Q1
$31K Sell
4,285
-345
-7% -$1.71K ﹤0.01% 3303
2015
Q4
$16K Hold
4,630
﹤0.01% 3500
2015
Q3
$13K Buy
4,630
+1,040
+29% +$3.55K ﹤0.01% 3583
2015
Q2
$14K Hold
3,590
﹤0.01% 3586
2015
Q1
$13K Hold
3,590
﹤0.01% 3560
2014
Q4
$11K Hold
3,590
﹤0.01% 3644
2014
Q3
$11K Hold
3,590
﹤0.01% 3632
2014
Q2
$7K Buy
+3,590
New +$7K ﹤0.01% 3762

Other funds holding MNOV

BlackRock Investment Management's MNOV Position: Q4 2016 in Review

BlackRock Investment Management increased its MediciNova (MNOV) stake by 0.7% in Q4 2016, buying an estimated $5.49K and bringing the position to 112,144 shares worth $676K. The position accounts for ﹤0.01% of the portfolio, ranked #2913.

BlackRock Investment Management first reported a position in MNOV in Q2 2014 and has held it in 11 quarters since. The position peaked at $842K in Q2 2016. 53 funds tracked by Wall St. Rank hold MNOV as of Q4 2016.

  • BlackRock Investment Management held 112,144 shares of MediciNova worth $676K as of Q4 2016.
  • BlackRock Investment Management bought 779 MediciNova shares in Q4 2016, an estimated $5.49K.
  • MediciNova made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2913 holding.
  • BlackRock Investment Management first reported a position in MediciNova in Q2 2014 and has held it in 11 quarters since.
  • BlackRock Investment Management's MediciNova position peaked at $842K in Q2 2016.
  • 53 funds tracked by Wall St. Rank held MediciNova as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.